Weichai Power stock rating downgraded to Neutral by UBS amid 50% rally

UBS downgraded Weichai Power (HK:2338) to Neutral from Buy, despite a slight price target increase to HK$18.50, citing the stock's significant 50% year-to-date rally which has rendered its current 10x 2026 P/E valuation fair. The firm believes positive factors like strong data center engine demand and trade-in subsidies are already priced in, while concurrently reducing 2025-2027 earnings estimates by 2-5% below consensus due to concerns over the traditional engine business and e-truck risks.

Analysis

UBS has downgraded Weichai Power (HK:2338) to Neutral from Buy, a move driven primarily by valuation concerns following a significant 50% year-to-date share price appreciation that has substantially outpaced the Hang Seng Index. The bank views the current valuation, at a 10x 2026 estimated price-to-earnings ratio, as fair given the company's projected 9% earnings CAGR for 2024-2027. This suggests the market has already priced in key positive catalysts, including strong demand for data center engines and the benefits of trade-in subsidies. Underscoring this cautious stance, UBS has lowered its 2025-2027 earnings estimates for Weichai by 2-5%, citing a "lacklustre traditional engine business" facing disruption from the increasing adoption of electric trucks. These revised forecasts position UBS 1-8% below consensus, indicating a more bearish outlook on core business performance than the broader market.

Key Decisions for Investors

• Investors who have held Weichai Power through its 50% rally should consider trimming positions to realize gains, as the stock is now considered fairly valued by UBS with limited further upside priced in.
• Potential new investors should exercise caution, as the downgrade to Neutral suggests a less favorable risk/reward profile at the current share price.
• Monitor the company's traditional engine segment performance and the pace of e-truck adoption, as these represent key risks to future earnings and are central to UBS's below-consensus estimates.